Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.

http://www.wikidata.org/entity/Q51429519

about

Adiponectin and atherosclerosis in rheumatoid arthritis Cord blood leptin levels of healthy neonates are associated with IFN-γ production by cord blood T-cells.Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis.The role of adipokines in connective tissue diseases.Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk Association of serum adiponectin, leptin, and resistin concentrations with the severity of liver dysfunction and the disease complications in alcoholic liver disease.Prevalence of fracture and osteoporosis risk factors in American Indian and Alaska Native people Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?Cardiometabolic comorbidities and rheumatic diseases: focus on the role of fat mass and adipokines.What's new in our understanding of the role of adipokines in rheumatic diseases?Adiponectin and leptin: new targets in inflammation.Roles of leptin in bone metabolism and bone diseases.Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.Decrease of Markers Related to Bone Erosion in Serum of Patients with Musculoskeletal Disorders after Serial Low-Dose Radon Spa Therapy.TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study.Serum levels of leptin and adiponectin and clinical parameters in women with fibromyalgia and overweight/obesity.Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis.

P2860

Q33790971-1567E684-94B3-4B7B-925A-5D4F1E045EE6 Q34345275-2236A2AD-A93A-4B5A-B3EF-B122635EFBB0 Q34346418-86A58F07-85E9-4A76-9955-FD6942136474 Q35089525-1F2F9134-C697-4A54-9A94-A2DA6C93F4D3 Q36095970-826B4582-27C3-4022-B44B-1B5554170828 Q36420973-4128C5BF-E9D5-4DBC-9B3A-E06FA4B4C49C Q36456346-D94C8597-7683-437D-9764-D624CE4B22D2 Q36830486-82086EF4-469E-4916-8261-6AABB43BD926 Q37292169-39013CDC-6B80-4410-B0F6-136F096D44A7 Q37298230-028AA800-448D-418E-BFD5-93C4EAC64C40 Q37380362-72A50F04-EB0E-4FC8-9B83-45DE5C498203 Q37686803-34EF81F9-C34D-4754-BDD9-8BB809792F23 Q37845275-562EE593-E544-4814-BB3B-723D324D9B56 Q37869467-713B2167-2F20-47A9-B734-FC2D58C15DAF Q37909903-49979793-BE3A-4CC8-9111-EB8C4D820CDD Q38120068-18C13D98-3B66-4681-B023-9BF7E1CD1910 Q38380562-B2982F51-0976-4531-9DF4-A94FE792ED61 Q38993250-A1C4C3A6-D59D-4B3B-B365-2548C0051358 Q41108607-A142EB5E-C3AA-4643-BF02-3463DDB80E5D Q43951812-5D70E5C7-4046-4430-9EE9-31DB77C65633 Q47573772-FFD5E164-AD84-4566-99C9-15465BC94AFB Q51135653-F63179F9-A0AC-4694-BB45-A0F6C352E5FC

P2860

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.

http://www.wikidata.org/entity/Q51429519

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Circulating leptin and adipone ...... h active rheumatoid arthritis.

@en

Circulating leptin and adipone ...... h active rheumatoid arthritis.

@nl

type

label

Circulating leptin and adipone ...... h active rheumatoid arthritis.

@en

Circulating leptin and adipone ...... h active rheumatoid arthritis.

@nl

prefLabel

Circulating leptin and adipone ...... h active rheumatoid arthritis.

@en

Circulating leptin and adipone ...... h active rheumatoid arthritis.

@nl

P1433

Q51429519-B2475046-4D76-4D23-B318-B6972935543D

P1476

Q51429519-9FD89AA0-81A4-4B22-A887-7DCB318E8AAF

P2093

Q51429519-17078B8C-48B6-4ED0-B97E-E466D44CCDC3

Q51429519-1BE29AF8-748F-4B15-B29F-2F39D6414A99

Q51429519-1D1D0E87-83B4-4C67-82E0-F11313566FFD

Q51429519-387AC1DF-0F09-47F1-87A9-42C392E5CF0D

Q51429519-520E1F65-C0CA-4FFB-860D-BE8D6BF8C836

Q51429519-520F5D0D-ABFB-4A37-BC70-90EE5D402AE1

Q51429519-651E5134-A024-4199-921A-D0E9D3DABEB7

Q51429519-9912B28F-5A44-4D6A-BC57-AF12B634106E

Q51429519-AD5B85B1-D139-4E67-9729-69897D0BA1C8

Q51429519-C01A7127-DE29-400B-BC8D-FCEEAA5FA36B

P304

Q51429519-02A52B93-B0B6-485E-A316-FD59388C1AD5

P31

Q51429519-17974F21-8B8B-4C66-9E3B-EBFFE947E118

P356

Q51429519-678E2025-5721-4210-ACD5-37F9AEF5B145

P407

Q51429519-4B170251-C327-48BD-B505-9D0B3E0116F4

P433

Q51429519-F443BCCA-FC0D-4FAF-A315-3CCF2FE8DE9E

P478

Q51429519-6848BF3E-0809-4163-8B78-0C658E16FF20

P577

Q51429519-CCBC93C8-0E3C-4265-A0B1-08A38CF8C5C1

P5875

Q51429519-13C29D25-D3DC-4721-B08B-4C3A13EAFE86

P698

Q51429519-9C16EE5A-6686-40C7-88A1-F9B4AD0E294E

P356

P1433

The Journal of Rheumatology

P1476

Circulating leptin and adipone ...... h active rheumatoid arthritis.

@en

P2093

Anton F H Stalenhoef

http://www.w3.org/2001/XMLSchema#string

Calin Popa

http://www.w3.org/2001/XMLSchema#string

Frank H J van den Hoogen

http://www.w3.org/2001/XMLSchema#string

Helga Toenhake-Dijkstra

http://www.w3.org/2001/XMLSchema#string

Jacqueline de Graaf

http://www.w3.org/2001/XMLSchema#string

Jos W M van der Meer

http://www.w3.org/2001/XMLSchema#string

Mihai G Netea

http://www.w3.org/2001/XMLSchema#string

Piet L C M van Riel

http://www.w3.org/2001/XMLSchema#string

Pilar Barrera

http://www.w3.org/2001/XMLSchema#string

Timothy R D J Radstake

http://www.w3.org/2001/XMLSchema#string

P304

724-730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3899/JRHEUM.080626

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24188777

http://www.w3.org/2001/XMLSchema#string

P698

19273452

http://www.w3.org/2001/XMLSchema#string